PASITHEA THERAPEUTICS CORP. Cash and Cash Equivalents, Period Increase (Decrease)
PASITHEA THERAPEUTICS CORP. (KTTA) reported Cash and Cash Equivalents, Period Increase (Decrease) of $20.32 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-18.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-11-18
- 2021-09-30: Cash and Cash Equivalents, Period Increase (Decrease) 9 month $20.32M.
- 2020-09-30: Cash and Cash Equivalents, Period Increase (Decrease) 5 month $9.03K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 5 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month |
|---|---|---|
| 2021-09-30 | $20.32M 10-Q · filed 2021-11-18 | |
| 2020-09-30 | $9.03K 10-Q · filed 2021-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |